Related Experiment Video
Updated: Nov 3, 2025

In vivo Evaluation of Mucociliary Clearance in Mice
Published on: December 18, 2020
Airway Epithelial Nucleotide Release Contributes to Mucociliary Clearance
Catharina van Heusden1, Barbara R Grubb1, Brian Button1
1Marsico Lung Institute/Cystic Fibrosis Center, School of Medicine, University of North Carolina, Chapel Hill, NC 27599-7248, USA.
Mucociliary clearance, vital for lung defense, relies on hydrated airways. This study identifies VNUT and pannexin 1 as key transporters regulating airway surface liquid volume and mucus clearance.
Area of Science:
- Pulmonary host defense
- Airway physiology
- Cellular transport mechanisms
Background:
- Mucociliary clearance (MCC) is crucial for lung health, but impaired in diseases like cystic fibrosis (CF) and chronic bronchitis (CB).
- Airway surface dehydration and mucus hyperconcentration characterize these obstructive lung diseases.
- Purinergic receptors on airway epithelia regulate mucus hydration via electrolyte transport, influenced by extracellular ATP and adenosine.
Purpose of the Study:
- To review evidence identifying key components of ATP release pathways in airway epithelial cells.
- To highlight the roles of the vesicular nucleotide transporter (VNUT) and pannexin 1 in regulating airway surface liquid (ASL) and MCC.
Main Methods:
- Review of existing evidence on vesicular and conducted pathways for ATP release.
- Focus on the identification and function of VNUT (SLC17A9) and pannexin 1.
- Examination of the impact of pannexin 1 ablation on ASL volume, ciliary beating, and MCC rates.
Main Results:
- VNUT facilitates ATP storage and release from secretory vesicles in airway epithelial cells.
- Pannexin 1 acts as an ATP conduit in non-mucous airway epithelial cells.
- Ablation of pannexin 1 significantly reduces ASL volume, ciliary beating, and MCC rates.
Conclusions:
- VNUT and pannexin 1 are critical regulators of airway purinergic signaling and MCC.
- Targeting these transporters may offer therapeutic strategies for lung diseases characterized by impaired mucus clearance.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Classification of Epithelial Tissues: Simple Epithelium
Because of the thinness of the cells, simple squamous epithelium is present where the rapid passage of chemical compounds is observed. For example, the endothelium that lines the capillaries and vessels...
Anatomy of Respiratory System I: Upper Respiratory Tract
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Breathing

